law.justia.com/cases/federal/district-courts/new-york/nysdce/1:2016cv05668/460419/67

Utts et al v. Bristol-Myers Squibb Company et al, No. 1:2016cv05668 - Document 67 (S.D.N.Y. 2017) case opinion from the Southern District of New York US ...

dockets.justia.com/docket/california/candce/4:2018cv04931/330591

Aug 14, 2018 ... Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability case filed on August 14, 2018 in the California Northern District ...

caselaw.findlaw.com/us-6th-circuit/1878276.html

BRISTOL-MYERS SQUIBB COMPANY; Otsuka America Pharmaceutical, Inc., ... Claims Act (FCA), 31 U.S.C. § 3729 et seq., and several state-law analogues. ... and granted in part and denied in part BMS's motion, dismissing all of the qui tam  ...

www.iadclaw.org/publications-news/defensecounseljournal/supreme-court-strikes-another-blow-to-litigation-tourism-in-bristol-myers-squibb

In its landmark decision Bristol-Myers Squibb Company v. Superior Court of California, San Francisco County, et al., (“BMS”) the Supreme Court rejected this  ...

www.law360.com/cases/58e6506f2a2edd2f07000001

Oct 18, 2018 ... Parties, docket activity and news coverage of federal case Bristol-Myers Squibb Company et al v. Mylan Pharmaceuticals Inc., case number ...

www.bms.com/researchers-and-partners/our-r-and-d-team/research-publications.html

All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care ..... Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients ...... Bethesda (MD): Eli Lilly & Company and the National Center for Advancing ...... in patients with impaired renal function: response to Hellfritzsch et al.